Published in Clin Exp Immunol on January 01, 1995
Mesenchymal tumours of the mediastinum-part I. Virchows Arch (2015) 0.78
Mesenchymal tumours of the mediastinum-part II. Virchows Arch (2015) 0.75
Orthopaedic case of the month: A 14-year-old boy with a medial thigh soft tissue mass. Clin Orthop Relat Res (2013) 0.75
Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer (1957) 9.27
Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proc Natl Acad Sci U S A (1987) 9.26
Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer (1972) 7.70
Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet (1983) 5.64
Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease. Blood (1989) 4.17
A systemic lymphoproliferative disorder with morphologic features of Castleman's disease: clinical findings and clinicopathologic correlations in 15 patients. J Clin Oncol (1985) 2.67
Angiomatoid malignant fibrous histiocytoma: a distinct fibrohistiocytic tumor of children and young adults simulating a vascular neoplasm. Cancer (1979) 1.74
Detection of cytokines at the cartilage/pannus junction in patients with rheumatoid arthritis: implications for the role of cytokines in cartilage destruction and repair. Br J Rheumatol (1992) 1.59
Localization of tumor necrosis factor receptors in the synovial tissue and cartilage-pannus junction in patients with rheumatoid arthritis. Implications for local actions of tumor necrosis factor alpha. Arthritis Rheum (1992) 1.53
Angiomatoid malignant fibrous histiocytoma. A follow-up study of 108 cases with evaluation of possible histologic predictors of outcome. Am J Surg Pathol (1990) 1.28
Influence of major histocompatibility complex class I and II antigens on survival in colorectal carcinoma. Cancer Res (1991) 1.03
Expression of HLA-D subloci DR and DQ by breast carcinomas is correlated with distinct parameters of favourable prognois. Eur J Cancer (1991) 0.87
Distribution of Langerhans cells and HLA class II molecules in prostatic carcinomas of different histopathological grade. Prostate (1991) 0.84
Expression of MHC class II antigens in human lung cancer cells. Virchows Arch B Cell Pathol Incl Mol Pathol (1991) 0.83
Control of the expression of a class II major histocompatibility gene (HLA-DR) in various human cell types: down-regulation by IL-1 but not by IL-6, prostaglandin E2, or glucocorticoids. Scand J Immunol (1990) 0.82
Angiomatoid malignant fibrous histiocytoma with extensive lymphadenopathy simulating Castleman's disease. Pediatr Pathol (1986) 0.79
Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet (1998) 8.20
Cooperating and controlling functions of thymus-derived lymphocytes in relation to autoimmunity. Lancet (1971) 7.98
Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages. J Clin Invest (1989) 7.60
Systemic lupus erythematosus syndrome induced by practolol. Br Med J (1973) 6.59
Phytochrome and Seed Germination. I. Temperature Dependence and Relative P(FR) Levels in the Germination of Dark-germinating Tomato Seeds. Plant Physiol (1967) 5.14
Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain (2009) 5.03
Equity of access to health care services: theory and evidence from the UK. Soc Sci Med (2001) 4.83
Concordance of the toxicity of pharmaceuticals in humans and in animals. Regul Toxicol Pharmacol (2000) 4.58
Attempt at deriving a formula for setting general practitioner fundholding budgets. BMJ (1994) 4.19
The BOADICEA model of genetic susceptibility to breast and ovarian cancer. Br J Cancer (2004) 4.06
Allocating resources to health authorities: development of method for small area analysis of use of inpatient services. BMJ (1994) 3.88
Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity. Nat Med (1999) 3.88
A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo. J Exp Med (2000) 3.65
The lymphocyte transformation test and gold hypersensitivity. Ann Rheum Dis (1968) 3.54
Persistent infection with Chlamydia pneumoniae following acute respiratory illness. Clin Infect Dis (1992) 3.30
Agriculture. Sustainable intensification in agriculture: premises and policies. Science (2013) 3.24
Acceptability, benefit and costs of early screening for hearing disability: a study of potential screening tests and models. Health Technol Assess (2007) 3.04
The human cytomegalovirus chemokine receptor US28 mediates vascular smooth muscle cell migration. Cell (1999) 2.97
Interferon gamma eliminates responding CD4 T cells during mycobacterial infection by inducing apoptosis of activated CD4 T cells. J Exp Med (2000) 2.91
Immunoregulatory role of interleukin 10 in rheumatoid arthritis. J Exp Med (1994) 2.90
The influence on survival of delay in the presentation and treatment of symptomatic breast cancer. Br J Cancer (1999) 2.89
Family study of the major histocompatibility complex in patients with systemic lupus erythematosus: importance of null alleles of C4A and C4B in determining disease susceptibility. Br Med J (Clin Res Ed) (1983) 2.86
Complement deficiency and disease. Immunol Today (1991) 2.77
IL-9-deficient mice establish fundamental roles for IL-9 in pulmonary mastocytosis and goblet cell hyperplasia but not T cell development. Immunity (2000) 2.74
A development of the Landis technique for measuring the filtration coefficient of individual capillaries in the frog mesentery. Q J Exp Physiol Cogn Med Sci (1974) 2.65
Systemic lupus erythematosus, complement deficiency, and apoptosis. Adv Immunol (2000) 2.59
Phytochrome and Seed Germination. III. Action of Prolonged Far Red Irradiation on the Germination of Tomato and Cucumber Seeds. Plant Physiol (1967) 2.54
Widespread West Nile virus activity, eastern United States, 2000. Emerg Infect Dis (2001) 2.52
Osteoprotegerin inhibits prostate cancer-induced osteoclastogenesis and prevents prostate tumor growth in the bone. J Clin Invest (2001) 2.49
Development of minimum criteria for the initiation of antibiotics in residents of long-term-care facilities: results of a consensus conference. Infect Control Hosp Epidemiol (2001) 2.45
HPV testing in primary screening of older women. Br J Cancer (1999) 2.44
Failure of cytotoxic drugs to suppress immune responses of patients with rheumatoid arthritis. Ann Rheum Dis (1970) 2.42
Effect of maximizing oxygen delivery on morbidity and mortality rates in critically ill patients: a prospective, randomized, controlled study. Crit Care Med (1993) 2.42
One year's treatment with propranolol after myocardial infarction: preliminary report of Norwegian multicentre trial. Br Med J (Clin Res Ed) (1982) 2.39
Complement facilitates early prion pathogenesis. Nat Med (2001) 2.30
Glucose utilization in vivo by human pulmonary neoplasms. Cancer (1987) 2.29
Immunohistochemical determination of oestrogen receptor: comparison of different methods of assessment of staining and correlation with clinical outcome of breast cancer patients. Br J Cancer (1996) 2.28
The emergence of West Nile virus in North America: ecology, epidemiology, and surveillance. Curr Top Microbiol Immunol (2002) 2.27
"Proximal-type" epithelioid sarcoma, a distinctive aggressive neoplasm showing rhabdoid features. Clinicopathologic, immunohistochemical, and ultrastructural study of a series. Am J Surg Pathol (1997) 2.25
The effect of brief halothane anesthesia during daily gavage on complications and body weight in rats. Contemp Top Lab Anim Sci (2001) 2.25
Antiphospholipid antibodies after myocardial infarction and their relation to mortality, reinfarction, and non-haemorrhagic stroke. Lancet (1992) 2.22
Inhibitory effect of non-steroidal anti-inflammatory drugs on mucosal cell proliferation associated with gastric ulcer healing. Lancet (1990) 2.22
Changes in the life-span of circulating small lymphocytes in mice after treatment with anti-lymphocyte globulin. Lancet (1968) 2.21
Identification of an anti-monocyte monoclonal antibody that is specific for membrane complement receptor type one (CR1). Eur J Immunol (1984) 2.20
Clinical course and prognostic factors following bone recurrence from breast cancer. Br J Cancer (1998) 2.20
C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction. J Exp Med (1999) 2.17
Cyclin D1 and prognosis in human breast cancer. Int J Cancer (1996) 2.11
Dissociation of neutrophil emigration and metabolic activity in lobar pneumonia and bronchiectasis. Eur Respir J (1997) 2.10
Infection control for home health. Infect Control Hosp Epidemiol (1990) 2.09
Pneumococcal diversity: considerations for new vaccine strategies with emphasis on pneumococcal surface protein A (PspA). Clin Microbiol Rev (1998) 2.06
Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes. Q J Med (1990) 2.03
Yes-associated protein (YAP) functions as a tumor suppressor in breast. Cell Death Differ (2008) 2.03
Comparison of sensitivities to two commercially available tuberculin skin test reagents in persons with recent tuberculosis. Clin Infect Dis (1997) 2.02
Expression of the ERBB3 gene product in breast cancer. Br J Cancer (1992) 2.01
Insights into interfacial activation from an open structure of Candida rugosa lipase. J Biol Chem (1993) 1.99
Natural history of autoimmune thyroiditis. Br Med J (Clin Res Ed) (1981) 1.99
Temporary depletion of complement component C3 or genetic deficiency of C1q significantly delays onset of scrapie. Nat Med (2001) 1.99
Mode of action of anti-lymphocyte globulin. I. The distribution of rabbit anti-lymphocyte globulin injected into rats and mice. Immunology (1968) 1.98
Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion. Cancer Res (1993) 1.97
Effects on the right ventricle, pulmonary vasculature, and carotid bodies of the rat of exposure to, and recovery from, simulated high altitude. Thorax (1973) 1.95
p53 immunostaining as a marker of malignant disease in diagnostic cytopathology. Lancet (1991) 1.95
Fulvine and the pulmonary circulation. Thorax (1971) 1.94
latheo encodes a subunit of the origin recognition complex and disrupts neuronal proliferation and adult olfactory memory when mutant. Neuron (1999) 1.94
Cardiac abnormalities in systemic lupus erythematosus. Association with raised anticardiolipin antibodies. Circulation (1990) 1.91
Pharmacokinetics of sulfadoxine and pyrimethamine in intermittent preventive treatment of malaria in pregnancy. Clin Pharmacol Ther (2009) 1.90
The effects of proteins upon the filtration coefficient of individually perfused frog mesenteric capillaries. Microvasc Res (1977) 1.89
In vivo measurement of neutrophil activity in experimental lung inflammation. Am J Respir Crit Care Med (1994) 1.88
Widespread distribution of a single drug rifampicin formulation of inferior bioavailability in South Africa. Int J Tuberc Lung Dis (2002) 1.87
Insulinotropic actions of exendin-4 and glucagon-like peptide-1 in vivo and in vitro. Metabolism (2001) 1.87
Prevention of C5 activation ameliorates spontaneous and experimental glomerulonephritis in factor H-deficient mice. Proc Natl Acad Sci U S A (2006) 1.87
The histopathology of 36 cases of plexogenic pulmonary arteriopathy. Histopathology (1990) 1.85
Arabidopsis consensus intron sequences. Plant Mol Biol (1996) 1.85
Aminorex and the pulmonary circulation. Thorax (1971) 1.83
Measurement of health-related quality of life for people with dementia: development of a new instrument (DEMQOL) and an evaluation of current methodology. Health Technol Assess (2005) 1.83
Replantation. Br Med J (Clin Res Ed) (1983) 1.81
Motor neuron disease in England and Wales, 1959-1979. J Neurol Neurosurg Psychiatry (1983) 1.81
Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomised controlled trial. Lancet (2003) 1.80
Identification and partial characterization of an exercise-induced neutrophil chemotactic factor in bronchial asthma. J Clin Invest (1982) 1.77
Intraoperative photodynamic therapy for malignant mesothelioma. Ann Thorac Surg (1990) 1.77
Family studies of erythrocyte complement receptor type 1 levels: reduced levels in patients with SLE are acquired, not inherited. Clin Exp Immunol (1985) 1.76
Risk factors for ovarian cancer: a case-control study. Br J Cancer (1989) 1.76
A multicenter, double-blind, placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting. Circulation (1995) 1.70
Placental-specific insulin-like growth factor 2 (Igf2) regulates the diffusional exchange characteristics of the mouse placenta. Proc Natl Acad Sci U S A (2004) 1.69
Measuring the fate of plant diversity: towards a foundation for future monitoring and opportunities for urgent action. Philos Trans R Soc Lond B Biol Sci (2005) 1.68
Neurological complications in Behçet's syndrome. Brain (1999) 1.68
EXPERIMENTAL NEPHRITIS IN THE FROG : I. THE ANATOMICAL EVIDENCE OF DAMAGE. J Exp Med (1930) 1.68
A morphological and immunocytochemical study of a distinctive variant of ductal carcinoma in-situ of the breast. Histopathology (1985) 1.67
Human papillomavirus types 16 and 18 in carcinomas of the penis from Brazil. Int J Cancer (1986) 1.67
Statin use is associated with reduced mortality in COPD. Eur Respir J (2006) 1.66
Haloperidol and nucleus accumbens dopamine depletion suppress lever pressing for food but increase free food consumption in a novel food choice procedure. Psychopharmacology (Berl) (1991) 1.65
Increasing rate of deliberate self poisoning. BMJ (1994) 1.65
Targeted deletion of the CD59 gene causes spontaneous intravascular hemolysis and hemoglobinuria. Blood (2001) 1.65
Use of C-reactive protein as a predictor of chorioamnionitis in preterm prelabour rupture of membranes: a systematic review. BJOG (2007) 1.64
The alkaline protease of Aspergillus fumigatus is not a virulence determinant in two murine models of invasive pulmonary aspergillosis. Infect Immun (1993) 1.63
Array-based DNA methylation profiling in follicular lymphoma. Leukemia (2009) 1.63
Monoclonal anti-TNF alpha antibody as a probe of pathogenesis and therapy of rheumatoid disease. Immunol Rev (1995) 1.63
Two Epstein-Barr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumour-suppressor Bim: clues to the pathogenesis of Burkitt's lymphoma. Oncogene (2007) 1.62